Sbi Pharmaceuticals Co., Ltd.

The University of Tokyo

Takeo Kohda

Tohru Tanaka

Motowo Nakajima

Satofumi Kawata

Kiyoshi Kita

Fuminori Abe

A method for ameliorating and/or preventing chronic kidney disease includes administering to a subject in need thereof an agent containing 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt thereof as an active ingredient. Preferably, these ALAs contain a metal-containing compound, such as sodium ferrous citrate. The above-mentioned ALAs, ALA; various esters, such as ALA methylester, ALA ethylester, ALA propylester, ALA butylester, and ALA pentylester; and hydrochlorides, phosphates, and sulfates, and the like of these ALA esters are preferred examples.

Prophylactic agent for chronic kidney disease

Provided is an antimalarial drug which is useful for prevention and treatment of infectious diseases caused by malaria parasites. A preventive and/or therapeutic agent for malaria, which contains, as an active ingredient, 5-aminolevulinic acid (ALA), a derivative thereof, or a pharmacologically acceptable salt thereof, is used.

Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient

Growing community of inventors

Tokyo, Japan

Takeo Kohda